Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Peer Christiansen"'
Autor:
Buket Öztürk Esen, Rikke Nørgaard Pedersen, Deirdre Cronin-Fenton, Lene Mellemkjær, Timothy L. Lash, Bent Ejlertsen, Peer Christiansen, Mette Nørgaard
Publikováno v:
J Natl Cancer Inst
Pedersen, R N, Esen, B Ö, Mellemkjær, L, Christiansen, P, Ejlertsen, B, Lash, T L, Nørgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years after Primary Diagnosis ', Journal of the National Cancer Institute, vol. 114, no. 3, pp. 391–399 . https://doi.org/10.1093/jnci/djab202
Pedersen, R N, Esen, B O, Mellemkjaer, L, Christiansen, P, Ejlertsen, B, Lash, T L, Norgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis ', National Cancer Institute. Journal (Online), vol. 114, no. 3, pp. 391-399 . https://doi.org/10.1093/jnci/djab202
Pedersen, R N, Esen, B Ö, Mellemkjær, L, Christiansen, P, Ejlertsen, B, Lash, T L, Nørgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years after Primary Diagnosis ', Journal of the National Cancer Institute, vol. 114, no. 3, pp. 391–399 . https://doi.org/10.1093/jnci/djab202
Pedersen, R N, Esen, B O, Mellemkjaer, L, Christiansen, P, Ejlertsen, B, Lash, T L, Norgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis ', National Cancer Institute. Journal (Online), vol. 114, no. 3, pp. 391-399 . https://doi.org/10.1093/jnci/djab202
Background Extended, more effective breast cancer treatments have increased the prevalence of long-term survivors. We investigated the risk of late breast cancer recurrence (BCR), 10 years or more after primary diagnosis, and associations between pat
Autor:
Jens Overgaard, Tine Engberg Damsgaard, Mette Eline Brunbjerg, Thomas Bo Jensen, Peer Christiansen
Publikováno v:
Brunbjerg, M E, Jensen, T B, Christiansen, P, Overgaard, J & Engberg Damsgaard, T 2021, ' Reinforcement of the abdominal wall with acellular dermal matrix or synthetic mesh after breast reconstruction with the pedicled transverse rectus abdominis musculocutaneous flap. A prospective double-blind randomized study ', Journal of Plastic Surgery and Hand Surgery, vol. 55, no. 4, pp. 202-209 . https://doi.org/10.1080/2000656X.2020.1856673
Introduction: The pedicled transverse rectus abdominis musculocutaneous flap (p-TRAM) is a well-established option for autologous breast reconstruction (BR) but donor-site morbidity is still reported. The aim of the present study was to compare donor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78d27510e2cd96b2b5c68894dc5e7b9b
https://pure.au.dk/portal/da/publications/reinforcement-of-the-abdominal-wall-with-acellular-dermal-matrix-or-synthetic-mesh-after-breast-reconstruction-with-the-pedicled-transverse-rectus-abdominis-musculocutaneous-flap-a-prospective-doubleblind-randomized-study(1bfddc1e-1075-48ba-b412-c385ebc442e2).html
https://pure.au.dk/portal/da/publications/reinforcement-of-the-abdominal-wall-with-acellular-dermal-matrix-or-synthetic-mesh-after-breast-reconstruction-with-the-pedicled-transverse-rectus-abdominis-musculocutaneous-flap-a-prospective-doubleblind-randomized-study(1bfddc1e-1075-48ba-b412-c385ebc442e2).html
Autor:
Thomas Winther Buus, Erik Morre Pedersen, Kennet Thorup, Søren Redsted, Peer Christiansen, Mads Sandahl, Anders Bonde Jensen, Finn Rasmussen
Publikováno v:
European Radiology Experimental
European Radiology Experimental, Vol 5, Iss 1, Pp 1-11 (2021)
Buus, T W, Sandahl, M, Thorup, K S, Rasmussen, F, Redsted, S, Christiansen, P, Jensen, A B & Pedersen, E M 2021, ' Breast cancer : comparison of quantitative dual-layer spectral CT and axillary ultrasonography for preoperative diagnosis of metastatic axillary lymph nodes ', European Radiology Experimental, vol. 5, no. 1, 16 . https://doi.org/10.1186/s41747-021-00212-6
European Radiology Experimental, Vol 5, Iss 1, Pp 1-11 (2021)
Buus, T W, Sandahl, M, Thorup, K S, Rasmussen, F, Redsted, S, Christiansen, P, Jensen, A B & Pedersen, E M 2021, ' Breast cancer : comparison of quantitative dual-layer spectral CT and axillary ultrasonography for preoperative diagnosis of metastatic axillary lymph nodes ', European Radiology Experimental, vol. 5, no. 1, 16 . https://doi.org/10.1186/s41747-021-00212-6
Background Our aim was to compare the diagnostic performance of quantitative dual-layer spectral computed tomography (DLSCT) and axillary ultrasound (US) for diagnosing lymph node metastases in breast cancer patients. Methods DLSCT and axillary US we
Autor:
Erik Morre Pedersen, Kim Sivesgaard, Thomas Winther Buus, Peer Christiansen, Anders Bonde Jensen, Tanja Linde Fris
Publikováno v:
Buus, T W, Sivesgaard, K, Fris, T L, Christiansen, P M, Jensen, A B & Pedersen, E M 2020, ' Fat fractions from high-resolution 3D radial Dixon MRI for predicting metastatic axillary lymph nodes in breast cancer patients ', European journal of radiology open, vol. 7, 100284 . https://doi.org/10.1016/j.ejro.2020.100284
European Journal of Radiology Open, Vol 7, Iss, Pp 100284-(2020)
European Journal of Radiology Open
European Journal of Radiology Open, Vol 7, Iss, Pp 100284-(2020)
European Journal of Radiology Open
Highlights • High-Resolution 3D radial Dixon MRI allows for the creation of quantitative fat fraction images. • Lymph node fat fractions improves diagnostic performance of MRI to detect axillary lymph node metastases. • Lymph node fat fractions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8a170d7b907b7eee2f53f020254357
https://pure.au.dk/portal/da/publications/fat-fractions-from-highresolution-3d-radial-dixon-mri-for-predicting-metastatic-axillary-lymph-nodes-in-breast-cancer-patients(a59e89fc-97aa-439d-a770-7c56e4665706).html
https://pure.au.dk/portal/da/publications/fat-fractions-from-highresolution-3d-radial-dixon-mri-for-predicting-metastatic-axillary-lymph-nodes-in-breast-cancer-patients(a59e89fc-97aa-439d-a770-7c56e4665706).html
Autor:
Christian Godballe, Kristine Zøylner Swan, Viveque Egsgaard Nielsen, Peer Christiansen, Henrik Baymler Pedersen, Marie Riis Mortensen, Jens Faunø Thrane, Steen Joop Bonnema, Sten Schytte
Publikováno v:
Swan, K Z, Nielsen, V E, Godballe, C, Thrane, J F, Mortensen, M R, Schytte, S, Pedersen, H B, Christiansen, P & Bonnema, S J 2018, ' Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area? ', Endocrine, vol. 61, no. 2, pp. 308–316 . https://doi.org/10.1007/s12020-018-1637-x
Swan, K Z, Nielsen, V E, Godballe, C, Thrane, J F, Mortensen, M R, Schytte, S, Pedersen, H B, Christiansen, P & Bonnema, S J 2018, ' Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area? ', Endocrine, vol. 61, no. 2, pp. 308-316 . https://doi.org/10.1007/s12020-018-1637-x
Swan, K Z, Nielsen, V E, Godballe, C, Thrane, J F, Mortensen, M R, Schytte, S, Pedersen, H B, Christiansen, P & Bonnema, S J 2018, ' Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area? ', Endocrine, vol. 61, no. 2, pp. 308-316 . https://doi.org/10.1007/s12020-018-1637-x
PURPOSE: To investigate the association between the pre-operative serum TSH (s-TSH) level and differentiated thyroid carcinoma (DTC) in a mildly iodine-deficient area.METHODS: Patients undergoing surgery for thyroid nodular disease (TND) were include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aab10549ce73b23d0860ac433d6b5deb
https://vbn.aau.dk/da/publications/a7e1d251-6f89-4960-8450-5e12dfe20acb
https://vbn.aau.dk/da/publications/a7e1d251-6f89-4960-8450-5e12dfe20acb
Autor:
Per Løgstrup Poulsen, Esben Søndergaard, Niels Jessen, Mette Høgh Christensen, Lars C. Gormsen, Søren Nielsen, Peer Christiansen, Steen B. Pedersen
Publikováno v:
Søndergaard, E, Gormsen, L C, Christensen, M H, Pedersen, S B, Christiansen, P, Nielsen, S, Poulsen, P L & Jessen, N 2014, ' Chronic adrenergic stimulation induces brown adipose tissue differentiation in visceral adipose tissue ', Diabetic medicine : a journal of the British Diabetic Association, vol. 32, no. 2, 32(2), pp. e4-e8 . https://doi.org/10.1111/dme.12595
BACKGROUND: Recruitment of brown adipose tissue is a promising strategy to treat obesity and Type 2 diabetes, but the physiological effects of a large amount of metabolically active brown adipose tissue in humans are unknown.CASE REPORT: In the prese
Autor:
Stephen Hamilton-Dutoit, Anders Kjærsgaard, Peer Christiansen, Marianne Ewertz, Rebecca A. Silliman, Henrik Toft Sørensen, Marco Mele, Deirdre Cronin-Fenton, Timothy L. Lash, Bent Ejlertsen, Thomas P. Ahern
Publikováno v:
Cronin-Fenton, D P, Kjærsgaard, A, Ahern, T P, Mele, M, Ewertz, M, Hamilton-Dutoit, S, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Lash, T L & Silliman, R A 2017, ' Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study ', Acta Oncologica, vol. 59, no. 6, pp. 1155-1160 . https://doi.org/10.1080/0284186X.2017.1327720
Cronin-Fenton, D P, Kjærsgaard, A, Ahern, T P, Mele, M, Ewertz, M, Hamilton-Dutoit, S, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Lash, T L & Silliman, R A 2017, ' Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study ', Acta Oncologica, vol. 56, no. 9, pp. 1155-1160 . https://doi.org/10.1080/0284186X.2017.1327720
Cronin-Fenton, D P, Kjærsgaard, A, Ahern, T P, Mele, M, Ewertz, M, Hamilton-Dutoit, S, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Lash, T L & Silliman, R A 2017, ' Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study ', Acta Oncologica, vol. 56, no. 9, pp. 1155-1160 . https://doi.org/10.1080/0284186X.2017.1327720
BACKGROUND: Validation studies of the Danish Breast Cancer Group (DBCG) registry show good agreement with medical records for adjuvant treatment data, but inconsistent recurrence information. No studies have validated changes in menopausal status or
Publikováno v:
International Journal of Endocrinology and Metabolism
Mele, M, Rolighed, L, Jespersen, M L, Rejnmark, L & Christiansen, P 2016, ' Recurrence of Hyperparathyroid Hypercalcemia in a Patient With the HRPT-2 Mutation and a Previous Parathyroid Carcinoma in Hyperparathyroidism-Jaw Tumor Syndrome ', International Journal of Endocrinology and Metabolism, vol. 14, no. 2, e35424 . https://doi.org/10.5812/ijem.35424
Mele, M, Rolighed, L, Jespersen, M L, Rejnmark, L & Christiansen, P 2016, ' Recurrence of Hyperparathyroid Hypercalcemia in a Patient With the HRPT-2 Mutation and a Previous Parathyroid Carcinoma in Hyperparathyroidism-Jaw Tumor Syndrome ', International Journal of Endocrinology and Metabolism, vol. 14, no. 2, e35424 . https://doi.org/10.5812/ijem.35424
INTRODUCTION: Cancer in the parathyroid gland is rare, but parathyroid cancer is occasionally seen in relation to genetic abnormalities. Due to a limited amount of evidence, the optimal handling of these cases is not clear. Furthermore, the presence
Autor:
Maj-Britt Jensen, Peer Christiansen, Tove Filtenborg Tvedskov, Bent Ejlertsen, Eva Balslev, Niels Kroman
Publikováno v:
Tvedskov, T F, Jensen, M-B, Ejlertsen, B, Christiansen, P, Balslev, E & Kroman, N 2015, ' Prognostic significance of axillary dissection in breast cancer patients with micrometastases or isolated tumor cells in sentinel nodes : a nationwide study ', Breast Cancer Research and Treatment, vol. 153, no. 3, pp. 599-606 . https://doi.org/10.1007/s10549-015-3560-7
We estimated the impact of axillary lymph node dissection (ALND) on the risk of axillary recurrence (AR) and overall survival (OS) in breast cancer patients with micrometastases or isolated tumor cells (ITC) in sentinel nodes. We used the Danish Brea
Autor:
Lars Bastholt, Peer Christiansen, Christian Godballe, Christian Hjort Sørensen, Ulrik Pedersen, Stefano Christian Londero, Henrik Baymler Pedersen, Lena Specht, Annelise Krogdahl
Publikováno v:
Londero, S C, Godballe, C, Krogdahl, A, Bastholt, L, Specht, L, Sørensen, C H, Pedersen, H B, Pedersen, U & Christiansen, P 2008, ' Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease? ', Acta Oncologica, vol. 47, no. 3, pp. 451-457 . https://doi.org/10.1080/02841860701630242
Londero, S C, Godballe, C, Krogdahl, A, Bastholt, L, Specht, L, Sørensen, C H, Pedersen, H B, Pedersen, U & Christiansen, P 2008, ' Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease? ', Acta oncologica (Stockholm, Sweden), vol. 47, no. 3, pp. 451-7 . https://doi.org/10.1080/02841860701630242
Londero, S C, Godballe, C, Krogdahl, A, Bastholt, L, Specht, L, Sørensen, C H, Pedersen, H B, Pedersen, U & Christiansen, P 2007, ' Papillary microcarcinoma of the thyroid gland: Is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease? ', Acta Oncologica, pp. 1-7 . https://doi.org/10.1080/02841860701630242
Londero, S C, Godballe, C, Krogdahl, A, Bastholt, L, Specht, L, Sørensen, C H, Pedersen, H B, Pedersen, U & Christiansen, P 2008, ' Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease? ', Acta oncologica (Stockholm, Sweden), vol. 47, no. 3, pp. 451-7 . https://doi.org/10.1080/02841860701630242
Londero, S C, Godballe, C, Krogdahl, A, Bastholt, L, Specht, L, Sørensen, C H, Pedersen, H B, Pedersen, U & Christiansen, P 2007, ' Papillary microcarcinoma of the thyroid gland: Is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease? ', Acta Oncologica, pp. 1-7 . https://doi.org/10.1080/02841860701630242
Introduction. Papillary microcarcinomas (PMC) of the thyroid gland are defined according to The WHO Committee as papillary carcinomas measuring 10 mm or less in diameter. A large proportion of these tumours are found coincidentally in the treatment o